Beyond the Androgen Receptor: The Sequence, the Mutants, and New Avengers in the Treatment of Castrate-Resistant Metastatic Prostate Cancer.

MLA

Westaby, Daniel, et al. “Beyond the Androgen Receptor: The Sequence, the Mutants, and New Avengers in the Treatment of Castrate-Resistant Metastatic Prostate Cancer.” American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, vol. 41, June 2021, pp. e190–202. EBSCOhost, https://doi.org/10.1200/EDBK_321209.

APA

Westaby, D., Viscuse, P. V., Ravilla, R., de la Maza, M. de L. D. F., Hahn, A., Sharp, A., de Bono, J., Aparicio, A., & Fleming, M. T. (2021). Beyond the Androgen Receptor: The Sequence, the Mutants, and New Avengers in the Treatment of Castrate-Resistant Metastatic Prostate Cancer. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, 41, e190–e202. https://doi.org/10.1200/EDBK_321209

Chicago

Westaby, Daniel, Paul V Viscuse, Rahul Ravilla, Maria de Los Dolores Fenor de la Maza, Andrew Hahn, Adam Sharp, Johann de Bono, Ana Aparicio, and Mark T Fleming. 2021. “Beyond the Androgen Receptor: The Sequence, the Mutants, and New Avengers in the Treatment of Castrate-Resistant Metastatic Prostate Cancer.” American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 41 (June): e190–202. doi:10.1200/EDBK_321209.